SK3 Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SKTO research report →
Companywww.sk3group.com
SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form.
- CEO
- Artemus Mayor
- IPO
- 2008
- Employees
- 15
- HQ
- Los Angeles, CA, US
Price Chart
Valuation
- Market Cap
- $3.02K
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.94%
- Op Margin
- 50.24%
- Net Margin
- 32.14%
- ROE
- 133.35%
- ROIC
- 66.68%
Growth & Income
- Revenue
- $52.76M · 0.00%
- Net Income
- $16.96M · 0.00%
- EPS
- $2.43 · 0.00%
- Op Income
- $26.51M
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -5.45
- Avg Volume
- 62.38K
Get TickerSpark's AI analysis on SKTO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SKTO Coverage
We haven't published any research on SKTO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SKTO Report →